Real World Evidence Solutions Market Size, Share, By Component (Claims Data, Clinical Settings Data, Patient-Powered Data, Pharmacy Data, and Others), By Application (Drug Development, and Drug Approvals), By End- Use (Healthcare Payers, Healthcare Providers, Pharmaceutical and Medical Device Companies, and Others), and By Region (North America, Europe, Asia Pacific, Middle East and Africa, and South America) - Trends, Analysis and Forecast till 2034

Report Code: PMI531024 | Publish Date: June 2024 | No. of Pages: 183

Real World Evidence Solutions Market Trends

Used in Developing and Authorising Drugs:

To evaluate the safety and effectiveness of a treatment, traditional drug development mainly depends on randomized controlled clinical trials (RCTs). Due to the limitations of RCTs, RWE data offers insights into the efficacy of drugs in various real-world clinical situations and patient populations. A setting other than an RCT's controlled environment aids in evaluating a drug's effectiveness.